Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Remedy Pharmaceuticals

Request full access

Remedy Pharmaceuticals, Inc. - Home

New York City, United StatesFounded 2004Biotech & Life Sciences

About Remedy Pharmaceuticals

Remedy Pharmaceuticals is dedicated to developing innovative treatments for central nervous system (CNS) diseases and injuries, with a particular focus on stroke and cerebral edema. The company operates in the biopharmaceutical industry, targeting healthcare providers and patients affected by CNS conditions. Remedy Pharmaceuticals' business model revolves around the research, development, and commercialization of its core product, Cirara, which aims to improve patient outcomes in cases of large hemispheric infarction and other severe CNS-related conditions. The company generates revenue through the sale and licensing of its pharmaceutical products.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
5
Open positions
None listed
Dealroom signal
54.5/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2C

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit May 2017 $120M $120M Biogen —
EARLY VCEquity / VC Jan 2017 $3M $12M Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Remedy Pharmaceuticals website traffic

Latest recorded traffic for Remedy Pharmaceuticals is 710 monthly website visits, down 35.5% over the last three months. Remedy Pharmaceuticals's team declined 28.6% over the past year.

Latest monthly visits710 3-month web change-35.5% 1-year team growth-28.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Remedy Pharmaceuticals in the New York City ecosystem

Live from Dealroom

The Remedy Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Broadview Ventures

Other known investors4 additional known investors

  • Biogen
  • University of Maryland Baltimore County
  • Biosciences Research and Commercialization Center
  • University of Maryland Ventures
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Remedy Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Remedy Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.